These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38394460)

  • 1. Antimicrobial susceptibility profile of clinically relevant Bacteroides, Phocaeicola, Parabacteroides and Prevotella species, isolated by eight laboratories in the Netherlands.
    Boiten KE; Notermans DW; Rentenaar RJ; van Prehn J; Bode LGM; Maat I; van der Zwet W; Jansz A; Siebers TJH; Rossen JWA; de Greeff SC; Hendrickx APA; Kuijper EJ; Veloo ACM
    J Antimicrob Chemother; 2024 Apr; 79(4):868-874. PubMed ID: 38394460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial Susceptibility Profiles of Prevotella Species Determined by Gradient Test Method in Two Centers in Istanbul].
    Ülger Toprak N; Akgül Ö; Külekçi G; Söyletir G
    Mikrobiyol Bul; 2020 Apr; 54(2):246-256. PubMed ID: 32723280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
    Fernández-Canigia L; Litterio M; Legaria MC; Castello L; Predari SC; Di Martino A; Rossetti A; Rollet R; Carloni G; Bianchini H; Cejas D; Radice M; Gutkind G;
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility testing of Bacteroides species by disk diffusion: The NordicAST Bacteroides study.
    Stubhaug TT; Giske CG; Justesen US; Kahlmeter G; Matuschek E; Sundsfjord A; Skaare D;
    Anaerobe; 2023 Jun; 81():102743. PubMed ID: 37253399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
    Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.
    Fang H; Li X; Yan MK; Tong MK; Chow KH; Cheng VC; Ho PL
    Anaerobe; 2023 Aug; 82():102756. PubMed ID: 37429411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Houhoula DP; Legakis NJ; Tsakris A; Avlamis A
    J Antimicrob Chemother; 2008 Jul; 62(1):137-41. PubMed ID: 18385145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
    Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antimicrobial resistance genes in Bacteroides spp. and Prevotella spp. Dutch clinical isolates.
    Veloo ACM; Baas WH; Haan FJ; Coco J; Rossen JW
    Clin Microbiol Infect; 2019 Sep; 25(9):1156.e9-1156.e13. PubMed ID: 30802650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
    Liu CY; Huang YT; Liao CH; Yen LC; Lin HY; Hsueh PR
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3161-8. PubMed ID: 18625771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rosenblatt J; Venezia R; Gorbach SL; Queenan AM; Hecht DW
    Anaerobe; 2011 Aug; 17(4):147-51. PubMed ID: 21664469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
    Jamal W; Khodakhast FB; AlAzmi A; Sόki J; AlHashem G; Rotimi VO
    BMC Microbiol; 2020 Jan; 20(1):14. PubMed ID: 31941446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
    Wu PH; Chen CH; Lin HH; Tseng KH; Ko WC; Ho MW; Hsueh PR
    Int J Antimicrob Agents; 2023 Jul; 62(1):106822. PubMed ID: 37088437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.
    Snydman DR; Jacobus NV; McDermott LA; Goldstein EJ; Harrell L; Jenkins SG; Newton D; Patel R; Hecht DW
    Anaerobe; 2017 Feb; 43():21-26. PubMed ID: 27867083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.